ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 64 filers reported holding ARCUS BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,406,000 | -0.9% | 85,700 | -8.4% | 0.00% | 0.0% |
| Q4 2020 | $2,429,000 | +48.6% | 93,575 | -1.9% | 0.00% | +100.0% |
| Q3 2020 | $1,635,000 | -10.8% | 95,375 | +28.8% | 0.00% | -50.0% |
| Q2 2020 | $1,832,000 | +100.4% | 74,065 | +12.4% | 0.00% | +100.0% |
| Q1 2020 | $914,000 | +45.3% | 65,871 | +5.8% | 0.00% | 0.0% |
| Q4 2019 | $629,000 | +251.4% | 62,271 | +216.1% | 0.00% | – |
| Q3 2019 | $179,000 | +58.4% | 19,700 | +38.7% | 0.00% | – |
| Q2 2019 | $113,000 | -17.5% | 14,200 | +29.1% | 0.00% | – |
| Q1 2019 | $137,000 | +16.1% | 11,000 | 0.0% | 0.00% | – |
| Q4 2018 | $118,000 | -22.9% | 11,000 | 0.0% | 0.00% | – |
| Q3 2018 | $153,000 | +13.3% | 11,000 | 0.0% | 0.00% | – |
| Q2 2018 | $135,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $40,850,000 | 24.66% |
| Octagon Capital Advisors LP | 2,669,974 | $67,657,000 | 18.06% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $22,040,000 | 8.36% |
| BVF INC/IL | 3,960,948 | $100,370,000 | 4.85% |
| Finepoint Capital LP | 535,000 | $13,557,000 | 4.69% |
| PFM Health Sciences, LP | 3,346,458 | $84,799,000 | 3.24% |
| ACUTA CAPITAL PARTNERS, LLC | 167,500 | $4,244,000 | 2.36% |
| Boxer Capital, LLC | 1,432,200 | $36,292,000 | 2.30% |
| Parkman Healthcare Partners LLC | 171,214 | $4,339,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 311,782 | $7,901,000 | 1.59% |